Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis

INTRODUCTION: Adalimumab and etanercept are drugs used in anti-TNF therapy in patients with psoriasis and psoriatic arthritis. Despite the molecular targeting of these drugs, the loss of pharmacological response to treatment is observed in patients. The development of personalized medicine makes it...

Descripción completa

Detalles Bibliográficos
Autores principales: Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Swinarew, Andrzej S., Rozwadowska, Beata, Zmarzły, Nikola, Gola, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262816/
https://www.ncbi.nlm.nih.gov/pubmed/32489364
http://dx.doi.org/10.5114/ada.2020.94847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262816/
https://www.ncbi.nlm.nih.gov/pubmed/32489364
http://dx.doi.org/10.5114/ada.2020.94847

Ejemplares similares